N-[[3-(2-methylimidazo[1,2-a]pyridin-3-yl)phenyl]methyl]-5H-chromeno[3,4-c]pyridine-8-carboxamide
C28H22N4O2 — CID 121363507
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[3-(2-methylimidazo[1,2-a]pyridin-3-yl)phenyl]methyl]-5H-chromeno[3,4-c]pyridine-8-carboxamide
N-[[3-(2-methylimidazo[1,2-a]pyridin-3-yl)phenyl]methyl]-5H-chromeno[3,4-c]pyridine-8-carboxamide (PubChem CID 121363507) has the molecular formula C28H22N4O2 and a molecular weight of 446.51 g/mol. Its IUPAC name is N-[[3-(2-methylimidazo[1,2-a]pyridin-3-yl)phenyl]methyl]-5H-chromeno[3,4-c]pyridine-8-carboxamide.
Molecular Properties
| Compound Name | N-[[3-(2-methylimidazo[1,2-a]pyridin-3-yl)phenyl]methyl]-5H-chromeno[3,4-c]pyridine-8-carboxamide |
|---|---|
| PubChem CID | 121363507 |
| Molecular Formula | C28H22N4O2 |
| Molecular Weight | 446.51 g/mol |
| Exact Mass | 446.17 |
| IUPAC Name | N-[[3-(2-methylimidazo[1,2-a]pyridin-3-yl)phenyl]methyl]-5H-chromeno[3,4-c]pyridine-8-carboxamide |
| SMILES | Cc1nc2ccccn2c1-c1cccc(CNC(=O)c2ccc3c(c2)OCc2cnccc2-3)c1 |
| InChI | InChI=1S/C28H22N4O2/c1-18-27(32-12-3-2-7-26(32)31-18)20-6-4-5-19(13-20)15-30-28(33)21-8-9-24-23-10-11-29-16-22(23)17-34-25(24)14-21/h2-14,16H,15,17H2,1H3,(H,30,33) |
| InChIKey | XLANSXXNDRUZDV-UHFFFAOYSA-N |
| XLogP | 5.19 |
| TPSA | 68.52 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.51 |
| LogP ≤ 5 | 5.19 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121363507 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.